The Einstein/Cornell collaborative protocol to assess efficacy and methodology in captopril scintirenography. Early results in patients with essential hypertension. Report of the Einstein/Cornell Collaborative Hypertension Group.
We have established an ongoing prospective investigation of hypertensive patients to examine the rates of false results in captopril scintirenography. This study is being conducted at the Albert Einstein College of Medicine and the Cornell University Medical Center. Two large populations will allow an accurate assessment of both false positive and false negative results. We report here the results from the first 30 patients, results which will be useful in defining the bounds for future studies.
Fine
E J
EJ
Albert Einstein College of Medicine, Department of Nuclear Medicine, Bronx, NY 10461.
Blaufox
M D
MD
D000328:Adult; D000368:Aged; D002216:Captopril; D002985:Clinical Protocols; D005188:False Negative Reactions; D005189:False Positive Reactions; D006801:Humans; D006973:Hypertension / Q000000981:diagnostic imaging* / Q000503:physiopathology; D006978:Hypertension, Renovascular / Q000000981:diagnostic imaging*; D008875:Middle Aged; D011446:Prospective Studies; D011866:Radioisotope Renography / Q000379:methods* / Q000592:standards; D012680:Sensitivity and Specificity
D002216:Captopril